Kandime TZ 250mg/31.25mg Injection
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Kandime TZ 250mg/31.25mg Injection
Tazocin 250mg/31.25mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance; adherence to the prescribed schedule is vital. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical intervention. Inform your doctor of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if experiencing somnolence or vertigo. Rest, proper nutrition, and hydration are crucial for optimal recovery. Your physician might order tests to monitor the drug's impact.
Primary Ingredients of Kandime TZ 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Kandime TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Kandime TZ 250mg/31.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Kandime TZ 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Kandime TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Kandime TZ 250mg/31.25mg Injection works:
Kandime TZ Injection (250mg/31.25mg) unites Ceftazidime, a bacterial cell wall synthesis inhibitor, with Tazobactum, a beta-lactamase inhibitor. This synergistic combination combats bacterial infections by disrupting bacterial defenses and boosting Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of Kandime TZ 250mg/31.25mg Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Kandime TZ 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data in humans are scarce.
Breast feedingSAFE IF PRESCRIBED
Kandime TZ 250mg/31.25mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, suggesting no infant harm.
DrivingUNSAFE
The injection Kandime TZ 250mg/31.25mg can cause drowsiness, visual disturbances, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Kandime TZ 250mg/31.25mg Injection cautiously; dosage modification may be necessary. Seek medical advice before use.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Kandime TZ 250mg/31.25mg Injection. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Kandime TZ 250mg/31.25mg Injection :
Should you forget a scheduled dose of Kandime TZ 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Kandime TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently